tbuckley/cabot-search huggingface dataset:
OUTCOMES OF CONTEMPORARY NON-INFERIORITY VERSUS SUPERIORITY CARDIOVASCULAR TRIALS
Authors: Isaac Dreyfus, Nicholas Varunok, Mahesh Madhavan, John Burton, Bjorn Redfors, Timothy Collier, Xavier Rossello, Ruth Owen, Dominic Francese, Nihar Desai, Joseph Ross, Sanjay Kaul, Stuart Pocock, Gregg Stone, Harlan Krumholz, Behnood Bikdeli
Journal: Journal of the American College of Cardiology (2021)
SUSTAINED REDUCTION IN PULMONARY ARTERY PRESSURES AND ALL HOSPITALIZATIONS DURING 2 YEARS OF AMBULATORY HEMODYNAMIC MONITORING
Authors: J. Thomas Heywood, David Shavelle, Robert Bourge, Maria Rosa Costanzo, Akshay Desai, Nirav Raval, Lisa Rathman, John Henderson, Marie-Elena Brett, Philip Adamson, Lynne Stevenson
Journal: Journal of the American College of Cardiology (2021)
Predictors of 30-Day Mortality Among Dutch Patients Undergoing Colorectal Cancer Surgery, 2011-2016
Authors: Tom van den Bosch, Anne-Loes K. Warps, Michael P. M. de Nerée tot Babberich, Christina Stamm, Bart F. Geerts, Louis Vermeulen, Michel W. J. M. Wouters, Jan Willem T. Dekker, Rob A. E. M. Tollenaar, Pieter J. Tanis, Daniël M. Miedema
Journal: JAMA Network Open (2021)

Quality improvement programs for colorectal cancer surgery have been introduced with benchmarking based on quality indicators, such as mortality. Detailed (pre)operative characteristics may offer relevant information for proper case-mix correction.To investigate the added value of machine learning to predict quality indicators for colorectal cancer surgery and identify previously unrecognized predictors of 30-day mortality based on a large, nationwide colorectal cancer registry that collected extensive data on comorbidities.All patients who underwent resection for primary colorectal cancer registered in the Dutch ColoRectal Audit between January 1, 2011, and December 31, 2016, were included. Multiple machine learning models (multivariable logistic regression, elastic net regression, support vector machine, random forest, and gradient boosting) were made to predict quality indicators. Model performance was compared with conventionally used scores. Risk factors were identified by logistic regression analyses and Shapley additive explanations (ie, SHAP values). Statistical analysis was performed between March 1 and September 30, 2020.The primary outcome of this cohort study was 30-day mortality. Prediction models were trained on a training set by performing 5-fold cross-validation, and outcomes were measured by the area under the receiver operating characteristic curve on the test set. Machine learning was further used to identify risk factors, measured by odds ratios and SHAP values.This cohort study included 62 501 records, most patients were male (35 116 [56.2%]), were aged 61 to 80 years (41 560 [66.5%]), and had an American Society of Anesthesiology score of II (35 679 [57.1%]). A 30-day mortality rate of 2.7% (n = 1693) was found. The area under the curve of the best machine learning model for 30-day mortality (0.82; 95% CI, 0.79-0.85) was significantly higher than the American Society of Anesthesiology score (0.74; 95% CI, 0.71-0.77; P < .001), Charlson Comorbidity Index (0.66; 95% CI, 0.63-0.70; P < .001), and preoperative score to predict postoperative mortality (0.73; 95% CI, 0.70-0.77; P < .001). Hypertension, myocardial infarction, chronic obstructive pulmonary disease, and asthma were comorbidities with a high risk for increased mortality. Machine learning identified specific risk factors for a complicated course, intensive care unit admission, prolonged hospital stay, and readmission. Laparoscopic surgery was associated with a decreased risk for all adverse outcomes.This study found that machine learning methods outperformed conventional scores to predict 30-day mortality after colorectal cancer surgery, identified specific patient groups at risk for adverse outcomes, and provided directions to optimize benchmarking in clinical audits.
Global patterns in anaphylaxis due to specific foods: A systematic review
Authors: Alessia Baseggio Conrado, Nandinee Patel, Paul J. Turner
Journal: Journal of Allergy and Clinical Immunology (2021)

BackgroundThere are increasing global data relating to prevalence of food allergy and food-induced anaphylaxis; however, this is often based on surrogate measures of sensitization rather than objective symptoms at food challenge. In terms of protecting food-allergic consumers from reactions, to our knowledge, there has been no global survey assessing geographic differences in the proportion of anaphylaxis triggered by specific foods.ObjectiveWe sought to identify common triggers for food-induced anaphylaxis and how these vary from country to country.MethodsSystematic review of relevant reports published between January 2010 and November 2020. Results were reported following PRISMA guidelines. Publications were screened and data extracted by 2 independent reviewers, and the risk of bias was assessed.ResultsSixty-five studies (encompassing 41 countries and all 6 regions as defined by the Food and Agriculture Organization of the United Nations) were included. Significant regional variations in the most common triggers of food anaphylaxis were seen; however, in general, there was good agreement between local legislative requirements for allergen disclosure and the most common allergens for each region or nation.ConclusionsLocal legislation for allergen disclosure generally reflects those allergens commonly responsible for food anaphylaxis. Cow's milk and crustaceans appear to cause a higher proportion of anaphylaxis compared to peanut in some regions. There are increasing global data relating to prevalence of food allergy and food-induced anaphylaxis; however, this is often based on surrogate measures of sensitization rather than objective symptoms at food challenge. In terms of protecting food-allergic consumers from reactions, to our knowledge, there has been no global survey assessing geographic differences in the proportion of anaphylaxis triggered by specific foods. We sought to identify common triggers for food-induced anaphylaxis and how these vary from country to country. Systematic review of relevant reports published between January 2010 and November 2020. Results were reported following PRISMA guidelines. Publications were screened and data extracted by 2 independent reviewers, and the risk of bias was assessed. Sixty-five studies (encompassing 41 countries and all 6 regions as defined by the Food and Agriculture Organization of the United Nations) were included. Significant regional variations in the most common triggers of food anaphylaxis were seen; however, in general, there was good agreement between local legislative requirements for allergen disclosure and the most common allergens for each region or nation. Local legislation for allergen disclosure generally reflects those allergens commonly responsible for food anaphylaxis. Cow's milk and crustaceans appear to cause a higher proportion of anaphylaxis compared to peanut in some regions.
RECOVERY OF CARDIAC FUNCTION FOLLOWING COVID-19 INFECTION: ECHOVID-19 - A LONGITUDINAL COHORT STUDY
Authors: Mats Højbjerg Lassen, Kristoffer Skaarup, Jannie N. Nørgaard, Alia Saed Alhakak, Morten Sengeløv, Anne Nielsen, Jakob Ø. Simonsen, Niklas D. Johansen, Henning Bundgaard, Christian Hassager, Jorn Carlsen, Reza Jabbari, Ole Kirk, Ole Peter Kristiansen, Olav W. Nielsen, Charlotte S. Ulrik, Peter Schnohr, Rasmus Mogelvang, Peter Sogaard, Morten K. Lamberts, Gorm B. Jensen, Kasper Iversen, Jens U.S. Jensen, Morten Schou
Journal: Journal of the American College of Cardiology (2021)
Abstract 17198: Asymmetric Bifurcation Angle of Common Iliac Artery is Associated With Unilateral Calcified Nodule Lesion of Common Iliac Artery
Authors: Nagataka Yoshihara, Hirokuni Akahori, Takahiro Imanaka, Kenji Kawai, Kojiro Miki, Koji Yanaka, Takamasa Tanaka, Tohru Masuyama, Masaharu Ishihara
Journal: Circulation (2018)

Background and aim: It has been known that bifurcation angles of common iliac artery (CIA) are not always bilateral symmetry. Previous study reported that mechanical stress initiate calcification in aortic valve. The aim of this study was to investigate the impact of CIA anatomical features on lesion characteristic of CIA. Methods and results: This study enrolled 72 patients with intermittent claudication who had undergone endovascular-therapy (EVT) for de novo CIA atherosclerotic lesions in our hospital during April 2012 to March 2017. Anatomical analysis of CIA bifurcation was assessed by frontal view of initial angiography at EVT. We calculated the bilateral CIA angles between axis of terminal aorta and axis of proximal CIA, and bilateral symmetry was expressed as absolute value of the difference between both CIA angles (Δangle). The patients were divided into 2 groups: symmetry group (Δangle≦10 degrees, n=40) and asymmetry group (Δangle&gt;10 degrees, n=32), according to the mean of Δangle. Distribution characteristics were classified into 2 patterns: bilateral lesions pattern and unilateral lesion pattern, furthermore we assessed calcified nodule of CIA lesion using intravascular ultrasound. There was no difference between 2 groups about patient characteristics. Unilateral lesion was observed in asymmetry group much more than symmetry group (63% vs 22%, P&lt;0.05). Calcified nodule lesion was observed in asymmetry group much more than symmetry group (28% vs 5%, P&lt;0.05). Conclusions: These findings suggested that asymmetric bifurcation angle of CIA was associated with unilateral lesion and calcified nodule lesion. Asymmetry of CIA bifurcation might be predictor of unilateral calcified nodule lesion of CIA.
Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension
Authors: Peter Heukels, Odilia B J Corneth, Denise van Uden, Jennifer A C van Hulst, Leon M van den Toorn, Annemien E van den Bosch, Marlies S Wijsenbeek, Karin A Boomars, Mirjam Kool, Rudi W Hendriks
Journal: Thorax (2021)

Introduction Autoreactivity against pulmonary vascular structures is thought to be involved in idiopathic pulmonary arterial hypertension (IPAH), but the underlying mechanisms remain poorly understood. We hypothesised that aberrant B-cell activation contributes to IPAH aetiology. Methods Mice with enhanced B-cell activation due to B-cell-specific overexpression of the B-cell receptor (BCR) signalling molecule Bruton’s tyrosine kinase (BTK) were subjected to lung injury and examined for several pulmonary hypertension (PH) indices. Peripheral blood lymphocytes from patients with IPAH (n=13), connective tissue disease-associated PAH (CTD-PAH, n=9), congenital heart disease PAH (n=7), interstitial lung disease associated PH (n=17) and healthy controls (n=19) were characterised by 14-colour flow cytometry. Results Following pulmonary injury, BTK-overexpressing mice showed prolonged activation of B cells and CXCR5 + follicular T-helper (Tfh) cells, as well as features of PH development. Patients with CTD-PAH and CHD-PAH displayed reduced proportions of circulating non-switched-memory B cells (p=0.03, p=0.02, respectively). Interestingly, we observed increased BTK protein expression in naive (p=0.007) and memory B-cell subsets of patients with IPAH and CTD-PAH. BTK was particularly high in patients with IPAH with circulating autoantibodies (p=0.045). IPAH patients had low frequencies of circulating CXCR5 + Tfh cells (p=0.005). Hereby, the increased BTK protein expression in B cells was associated with high proportions of Tfh17 (p=0.018) and Tfh17.1 (p=0.007) cells within the circulating Tfh population. Conclusions Our study shows that pulmonary injury in combination with enhanced B-cell activation is sufficient to induce PH symptoms in mice. In parallel, immune homeostasis in patients with IPAH is compromised, as evidenced by increased BCR signalling and cTfh17 polarisation, indicating that adaptive immune activation contributes to IPAH disease induction or progression.
Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases
Authors: Guang-Ming Ren, Jian Li, Xiao-Chun Zhang, Yu Wang, Yang Xiao, Xuan-Yi Zhang, Xian Liu, Wen Zhang, Wen-Bing Ma, Jie Zhang, Ya-Ting Li, Shou-Song Tao, Ting Wang, Kai Liu, Hui Chen, Yi-Qun Zhan, Miao Yu, Chang-Yan Li, Chang-Hui Ge, Bo-Xue Tian, Gui-Fang Dou, Xiao-Ming Yang, Rong-Hua Yin
Journal: Science Immunology (2021)

Thiolutin, an inhibitor of the BRISC deubiquitinating enzyme complex, specifically and potently inhibits NLRP3 inflammasome activation.
A COMMON CULPRIT AND AN IRISH DELAY: 5-FLUOROURACIL (5FU) INDUCED TRANSIENT MYOCARDITIS
Authors: Myles McKittrick, Seoidín Elizabeth McKittrick, Rory Gallen, Niamh Fitzhenry, Kevin Millar, Rory O'Hanlon, Deirdre Waterhouse, Alice Brennan, Syed F. Abbas, Terence Hennessy, Samer Arnous, Ihsan Ullah, Hani Muradagha, Thomas Kiernan, Stephen Tuohy
Journal: Journal of the American College of Cardiology (2021)
Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD
Authors: Nicholas A Kennedy, Simeng Lin, James R Goodhand, Neil Chanchlani, Benjamin Hamilton, Claire Bewshea, Rachel Nice, Desmond Chee, JR Fraser Cummings, Aileen Fraser, Peter M Irving, Nikolaos Kamperidis, Klaartje B Kok, Christopher Andrew Lamb, Jonathan Macdonald, Shameer Mehta, Richard Cg Pollok, Tim Raine, Philip J Smith, Ajay Mark Verma, Simon Jochum, Timothy J McDonald, Shaji Sebastian, Charlie W Lees, Nick Powell, Tariq Ahmad
Journal: Gut (2021)

Objective Delayed second dose SARS-CoV-2 vaccination trades maximal effectiveness for a lower level of immunity across more of the population. We investigated whether patients with inflammatory bowel disease treated with infliximab have attenuated serological responses to a single dose of a SARS-CoV-2 vaccine. Design Antibody responses and seroconversion rates in infliximab-treated patients (n=865) were compared with a cohort treated with vedolizumab (n=428), a gut-selective anti-integrin α4β7 monoclonal antibody. Our primary outcome was anti-SARS-CoV-2 spike (S) antibody concentrations, measured using the Elecsys anti-SARS-CoV-2 spike (S) antibody assay 3–10 weeks after vaccination, in patients without evidence of prior infection. Secondary outcomes were seroconversion rates (defined by a cut-off of 15 U/mL), and antibody responses following past infection or a second dose of the BNT162b2 vaccine. Results Geometric mean (SD) anti-SARS-CoV-2 antibody concentrations were lower in patients treated with infliximab than vedolizumab, following BNT162b2 (6.0 U/mL (5.9) vs 28.8 U/mL (5.4) p&lt;0.0001) and ChAdOx1 nCoV-19 (4.7 U/mL (4.9)) vs 13.8 U/mL (5.9) p&lt;0.0001) vaccines. In our multivariable models, antibody concentrations were lower in infliximab-treated compared with vedolizumab-treated patients who received the BNT162b2 (fold change (FC) 0.29 (95% CI 0.21 to 0.40), p&lt;0.0001) and ChAdOx1 nCoV-19 (FC 0.39 (95% CI 0.30 to 0.51), p&lt;0.0001) vaccines. In both models, age ≥60 years, immunomodulator use, Crohn’s disease and smoking were associated with lower, while non-white ethnicity was associated with higher, anti-SARS-CoV-2 antibody concentrations. Seroconversion rates after a single dose of either vaccine were higher in patients with prior SARS-CoV-2 infection and after two doses of BNT162b2 vaccine. Conclusion Infliximab is associated with attenuated immunogenicity to a single dose of the BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines. Vaccination after SARS-CoV-2 infection, or a second dose of vaccine, led to seroconversion in most patients. Delayed second dosing should be avoided in patients treated with infliximab. Trial registration number ISRCTN45176516 .
THE ROLE OF ABO BLOOD GROUP TYPING IN RISK STRATIFYING PATIENTS WITH THE NOVEL CORONAVIRUS 2019-NCOV
Authors: Husam Shadid, Michael Pan, Elizabeth Anderson, Tariq Azam, Hanna Berlin, Chelsea Meloche, Rafey Feroze, Patrick O’Hayer, Abbas Bitar, Kishan Padalia, Erinleigh Michaud, Christopher Launius, Penelope Blakely, Salim Hayek
Journal: Journal of the American College of Cardiology (2021)
Impact of an electronic medical record-based appointment order on outpatient cardiology follow-up after hospital discharge
Authors: Kartik S. Telukuntla, Chetan P. Huded, Mingyuan Shao, Tim Sobol, Mouin Abdallah, Kathleen Kravitz, Michael Hulseman, Benico Barzilai, Randall C. Starling, Lars G. Svensson, Steven E. Nissen, Umesh N. Khot
Journal: npj Digital Medicine (2021)

Abstract Outpatient follow-up after hospital discharge improves continuity of care and reduces readmissions, but rates of follow-up remain low. It is not known whether electronic medical record (EMR)-based tools improve follow-up. The aim of this study was to determine if an EMR-based order to secure cardiology follow-up appointments at hospital discharge would improve follow-up rates and hospital readmission rates. A pre-post interventional study was conducted and evaluated 39,209 cardiovascular medicine discharges within an academic center between 2012 and 2017. Follow-up rates and readmission rates were compared during 2 years prior to EMR-order implementation (pre-order era 2012–2013, n = 12,852) and 4 years after implementation (EMR-order era 2014–2017, n = 26,357). The primary endpoint was 90-day cardiovascular follow-up rates within our health system. In the overall cohort, the mean age of patients was 69.3 years [SD 14.7] and 60.7% ( n = 23,827) were male. In the pre-order era, 90-day follow-up was 56.7 ± 0.4% (7286 of 12,852) and increased to 67.9 ± 0.3% (17,888 of 26,357, P &lt; 0.001) in the EMR-order era. The use of the EMR follow-up order was independently associated with increased outpatient follow-up within 90 days after adjusting for patient demographics and payor status (OR 3.28, 95% CI 3.10–3.47, P &lt; 0.001). The 30-day readmission rate in the pre-order era was 12.8% (1642 of 12,852) compared with 13.7% (3601 of 26,357, P = 0.016) in the EMR-order era. An EMR-based appointment order for follow-up appointment scheduling was associated with increased cardiovascular medicine follow-up, but was not associated with an observed reduction in 30-day readmission rates.
PROGNOSTIC VALUE OF RIGHT VENTRICULAR SYSTOLIC PRESSURE (RVSP) IN PATIENTS HOSPITALIZED WITH HEART FAILURE
Authors: Monil M. Majmundar, Tikal Kansara, Hansang Park, Joanna Lenik, Kristine Gapuz, Nazia Khan, Fernando Quesada, Kuldeep Ghosh, Palak Shah, Ashish Kumar, Rajkumar Doshi, Tuoyo Mene-Afejuku, Harsh Patel, Samarthkumar Thakkar, Shobhana Chaudhari, Savi Mushiyev, Ferdinand Visco
Journal: Journal of the American College of Cardiology (2021)
Abstract 15548: Sirt1 Activation Restores Mitophagy-Mediated Clearance of Damaged Mitochondria and Ameliorates Dystrophic Cardiomyopathy in Mice
Authors: Atsushi Kuno, Ryusuke Hosoda, Yoshiyuki Horio
Journal: Circulation (2018)

Introduction: Elimination of damaged mitochondria via mitophagy maintains proper mitochondrial function. It is unclear whether impaired mitophagy underlies cardiomyopathy in muscular dystrophy. SIR...
EXTRACORPOREAL MEMBRANE OXYGENATION WITH BI-ATRIAL UNLOADING TO TREAT BIVENTRICULAR DYSFUNCTION
Authors: Gulmohar Singh-Kucukarslan, Mohamad Raad, Waleed Al-Darzi, Jennifer Cowger, Lizbeth Brice, Mir Basir, William O'Neill, Khaldoon Alaswaad, Marvin Eng
Journal: Journal of the American College of Cardiology (2021)
A rapidly magnetically assembled stem cell microtissue with “hamburger” architecture and enhanced vascularization capacity
Authors: Yuezhi Lu, Chun-Hua Yu, Guangzheng Yang, Ningjia Sun, Fei Jiang, Mingliang Zhou, Xiaolin Wu, Jiaxin Luo, Cui Huang, Wenjie Zhang, Xinquan Jiang
Journal: Bioactive Materials (2021)

With the development of magnetic manipulation technology based on magnetic nanoparticles (MNPs), scaffold-free microtissues can be constructed utilizing the magnetic attraction of MNP-labeled cells. The rapid
PRESENCE OF MYOCARDIAL FIBROTIC OR FAT CHANGE INFLUENCES THE WIDTH OF DISTRIBUTION RANGE OF J WAVES IN SURVIVORS OF VENTRICULAR FIBRILLATION WITHOUT ISCHEMIC HEART DISEASE
Authors: Nobusada Funabashi, Koki Nakamura, Masahiro Okamoto, Shigeto Naito, Yoshio Kobayashi
Journal: Journal of the American College of Cardiology (2021)
Prenatal paraben exposure and atopic dermatitis‐related outcomes among children
Authors: Loreen Thürmann, Gunda Herberth, Bettina Seiwert, Linda Schlittenbauer, Ulrike Rolle‐Kampczyk, Stefan Röder, Ulrich Sack, Michael Borte, Martin von Bergen, Saskia Trump, Thorsten Reemtsma, Irina Lehmann
Journal: Allergy (2021)

Parabens, widely used as preservatives in cosmetics, foods, and other consumer products, are suspected of contributing to allergy susceptibility. The detection of parabens in the placenta or amniotic fluid raised concerns about potential health consequences for the child. Recently, an increased asthma risk following prenatal exposure has been reported. Here, we investigated whether prenatal paraben exposure can influence the risk for atopic dermatitis (AD).261 mother-child pairs of the German mother-child study LINA were included in this analysis. Eight paraben species were quantified in maternal urine obtained at gestational week 34. According to the parental report of physician-diagnosed AD from age 1 to 8 years, disease onset, and persistence, childhood AD was classified into four different phenotypes.4.6% (n = 12) and 12.3% (n = 32) of the children were classified as having very early-onset AD (until age two) either with or without remission, 11.9% (n = 31) as early-onset (after age two), and 3.1% (n = 8) as childhood-onset AD (after age six). Exposure to ethylparaben and n-butylparaben was associated with an increased risk to develop very early-onset AD without remission (EtP: adj.OR/95% CI:1.44/1.04-2.00,nBuP:adj.OR/95% CI:1.95/1.22-3.12). The effects of both parabens were predominant in children without a history of maternal AD and independent of children's sex.Prenatal EtP or nBuP exposure may increase children's susceptibility for persistent AD with disease onset at very early age. This association was particularly pronounced in children without a history of maternal AD, indicating that children without a genetic predisposition are more susceptible to paraben exposure.
GLOBAL CARDIOVASCULAR RISK ASSESSMENT IMPROVES RISK STRATIFICATION FOR MAJOR ADVERSE CARDIAC EVENTS ACROSS A WIDE RANGE OF TRIGLYCERIDE LEVELS IN STATIN-TREATED INDIVIDUALS: INSIGHTS FROM THE KP REACH STUDY
Authors: Andrew P. Ambrosy, Jingrong Yang, Jesse Fitzpatrick, Jeffrey Wagner, Jeremy Kong, Sue Hee Sung, Amanda Allen, Sephy Philips, Craig Granowitz, David Abrahamson, Alan Go
Journal: Journal of the American College of Cardiology (2021)
SPORTS CLEARANCE FOLLOWING SARS-COV-2 INFECTION IN CHILDREN: DOES NONINVASIVE TESTING PREDICT ABNORMAL CARDIAC MRI?
Authors: Sara Kristen Sexson Tejtel, Emy Kuriakose, Michele Krenek, Tam Doan, Brian Snarr, Shagun Sachdeva, Steven Wolfe, James Wilkinson, David Brennen, Silvana Molossi
Journal: Journal of the American College of Cardiology (2021)
ABNORMAL AORTIC VALVE HEMODYNAMICS ASSOCIATED WITH A LACK OF IMPROVEMENT IN LEFT VENTRICLE FUNCTION AFTER VALVE-IN-VALVE TAVR
Authors: Vincent Chen, Andrew Peters, Fei Fei Gong, Eric Cantey, James Flaherty, S. Chris Malaisrie, Madeline Jankowski, Ashvita Ramesh, Kameswari Maganti
Journal: Journal of the American College of Cardiology (2021)
A community-based, multi-level, multi-setting, multi-component intervention to reduce weight gain among low socioeconomic status Latinx children with overweight or obesity: The Stanford GOALS randomised controlled trial
Authors: Thomas N Robinson, Donna Matheson, Darrell M Wilson, Dana L Weintraub, Jorge A Banda, Arianna McClain, Lee M Sanders, William L Haskell, K Farish Haydel, Kristopher I Kapphahn, Charlotte Pratt, Kimberly P Truesdale, June Stevens, Manisha Desai
Journal: The Lancet Diabetes & Endocrinology (2021)